tiprankstipranks
Trending News
More News >
Bionano Genomics (BNGO)
NASDAQ:BNGO
US Market

BioNano Genomics (BNGO) Financial Statements

Compare
9,208 Followers

BioNano Genomics Financial Overview

BioNano Genomics's market cap is currently $16.08M. The company's EPS TTM is $-2.04; its P/E ratio is -0.10; BioNano Genomics is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-1.36. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 30.78M$ 36.12M$ 27.80M$ 17.98M$ 8.50M
Gross Profit$ 380.00K$ 9.57M$ 5.95M$ 3.87M$ 2.77M
Operating Income$ -103.98M$ -215.25M$ -131.70M$ -77.10M$ -38.55M
EBITDA$ -97.47M$ -213.60M$ -120.31M$ -73.86M$ -35.57M
Net Income$ -112.02M$ -232.49M$ -132.60M$ -72.44M$ -41.11M
Balance Sheet
Cash & Short-Term Investments$ 9.47M$ 66.77M$ 113.19M$ 250.61M$ 38.45M
Total Assets$ 76.67M$ 214.40M$ 307.50M$ 377.10M$ 60.45M
Total Debt$ 27.30M$ 79.41M$ 11.67M$ 10.70M$ 16.32M
Net Debt$ 18.12M$ 61.47M$ 6.58M$ -13.88M$ -22.12M
Total Liabilities$ 41.30M$ 118.25M$ 58.10M$ 39.98M$ 25.37M
Stockholders' Equity$ 35.38M$ 96.16M$ 249.40M$ 337.12M$ 35.08M
Cash Flow
Free Cash Flow$ -69.03M$ -126.87M$ -128.12M$ -73.39M$ -38.31M
Operating Cash Flow$ -68.92M$ -125.18M$ -124.82M$ -71.93M$ -38.31M
Investing Cash Flow$ 73.84M$ 24.16M$ 82.77M$ -278.06M$ -2.45M
Financing Cash Flow$ -13.69M$ 113.81M$ 23.01M$ 336.11M$ 61.90M
Currency in USD

BioNano Genomics Earnings and Revenue History

BioNano Genomics Debt to Assets

BioNano Genomics Cash Flow

BioNano Genomics Forecast EPS vs Actual EPS